2017
DOI: 10.1016/j.intimp.2017.02.009
|View full text |Cite
|
Sign up to set email alerts
|

Fisetin inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
100
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 128 publications
(106 citation statements)
references
References 45 publications
4
100
0
Order By: Relevance
“…1, 2, and 3). Other natural CRMs, such as butein and fisetin (11,21,27,38,48,53,58,59), also inhibited T-cell activation (IC 50 = 2.8 μM and 5.2 μM, respectively) ( Figs. 1 and 3).…”
Section: Resultsmentioning
confidence: 94%
“…1, 2, and 3). Other natural CRMs, such as butein and fisetin (11,21,27,38,48,53,58,59), also inhibited T-cell activation (IC 50 = 2.8 μM and 5.2 μM, respectively) ( Figs. 1 and 3).…”
Section: Resultsmentioning
confidence: 94%
“…In addition, intra-articular injections of glucocorticoids and hyaluronic acid, used to relieve OA symptoms, have only temporary effects and are not capable of reversing the pathophysiological progression of OA [Hochberg et al, 2012;McAlindon et al, 2014]. Therefore, the number of studies investigating the mitigation of OA with medicinal plant extracts with relatively few side effects has increased, along with the use of nutraceuticals in the management of OA [Akhtar and Haqqi, 2012;Zheng et al, 2017;Lee et al, 2018a].…”
Section: Discussionmentioning
confidence: 99%
“…These catabolic factors continuously induce the inflammatory response of chondrocytes and degrade the extracellular matrix (ECM) of cartilage, thereby providing an environment suitable for OA development [Goldring and Goldring, 2004;Kobayashi et al, 2005;Blom et al, 2007]. In addition, IL-1β-induced increase in expression is found in the synovial fluid and cartilage tissue of patients with OA [Dieppe et al, 1999;Zheng et al, 2017]. Thus, a reduction in the activity of cartilage-degrading enzymes and inflammatory mediators is expected to have beneficial effects, such as chondroprotection, against pathological conditions like OA [Jeoun et al, 2016].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the mechanism of OA can be studied by focusing on signalling pathways. Studies have shown that the p38 mitogen‐activated protein kinase (MAPK) signalling pathway is activated and involved in progressive collagen type II degradation and destruction of cartilage matrix in the process of inflammation . In addition, studies by Joos et al have shown that p38 MAPK activation can cause pain in the patient's joints and lead to malignant circulation in the internal environment of articular cartilage .…”
Section: Introductionmentioning
confidence: 99%
“…Studies have shown that the p38 mitogen-activated protein kinase (MAPK) signalling pathway is activated and involved in progressive collagen type II degradation and destruction of cartilage matrix in the process of inflammation. 7 In addition, studies by Joos et al have shown that p38 MAPK activation can cause pain in the patient's joints and lead to malignant circulation in the internal environment of articular cartilage. 8 Phosphorylated Jun N-terminal kinase (JNK) increases the expression of matrix metalloproteinase through its downstream transcription factors, leading to progressive degradation of the chondrocyte extracellular matrix.…”
Section: Introductionmentioning
confidence: 99%